Vitrolife: Information Regarding the Distribution of Xvivo Perfusion AB
9/24/2012 10:06:17 AM
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR):
In accordance with the resolution adopted by the Extraordinary General Meeting of shareholders held on September 24, Vitrolife’s transplantation business, which is run in the subsidiary Xvivo Perfusion AB (”Xvivo”) and its subsidiaries, will be spun off to the shareholders through distribution of the shares in Xvivo in accordance with “Lex Asea”.
comments powered by